Market Closed - Warsaw S.E. 11:55:41 2024-04-26 am EDT 5-day change 1st Jan Change
90.4 PLN -1.09% Intraday chart for Voxel S.A. -1.31% +15.01%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Amadeus IT Group Buys Voxel Media in EUR113 Million Deal MT
Voxel S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Voxel S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Voxel S.A. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Voxel S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Micro-X Gets U.S. Approval for Product Development Extension MT
Voxel S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
Voxel S.A. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Voxel S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
Monex Group Unit to Launch Six Meebits MT
Voxel S.A. Reports Earnings Results for the Second Quarter Ended June 30, 2021 CI
Voxel S.A. Reports Earnings Results for the First Quarter Ended March 31, 2021 CI
Voxel S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2020 CI
Voxel S.A. Reports Earnings Results for the Third Quarter Ended September 30, 2020 CI
Voxel S.A. agreed to acquire 59.99% stake Rezonans Powisle Sp z o.o. for PLN 6.1 million. CI
Voxel S.A. acquired additional 49% stake in Exira Gamma Knife sp. z o.o. from a healthcare investments société à responsabilité limitée for PLN 11.1 million. CI
Voxel S.A. cancelled the acquisition of Rode-Med SA. CI
Voxel S.A. entered into a share purchase agreement to acquire 51% stake in Exira Gamma Knife sp. z o.o. from Voxel International S.À R.L. for PLN 5.8 million. CI
Voxel S.A. entered into a letter of intent to acquire Rode-Med SA. CI
Life Healthcare and Affidea Reportedly In Talks To Acquire Voxel CI
Voxel Appointed An Advisor For Strategic Options CI
Towarzystwo Funduszy Inwestycyjnych PZU SA through its funds acquired an additional 9.52% stake in Voxel S.A. CI
VOX In Talks With Business Partners CI
Polish Enterprise Fund VII, fund of Enterprise Investors completed the acquisition of Center for Cancer Diagnostics and Therapy from Voxel S.A.. CI
Polish Enterprise Fund VII, fund of Enterprise Investors reached an agreement to acquire Center for Cancer Diagnostics and Therapy from Voxel S.A. for PLN 11 million. CI
Chart Voxel S.A.
More charts
Voxel SA is a Poland-based company active in the healthcare sector. It provides services in the fields of diagnostic imaging, teleradiology and outsourcing, as well as information technology (IT) systems for hospitals and diagnostic centers. As of December 31, 2011, the Company operated two subsidiaries, 95.24%-owned Alteris SA and wholly owned CDO Sp. z o.o. On November 7, 2012, the Company sold its entire stake in Centrum Diagnostyki i Terapii Onkologicznej Sp. z o.o.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
90.4 PLN
Average target price
98 PLN
Spread / Average Target
+8.41%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. VOX Stock
  4. News Voxel S.A.
  5. Amadeus IT Group Buys Voxel Media in EUR113 Million Deal